Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bellus Health Inc (NQ: BLU ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bellus Health Inc < Previous 1 2 Next > From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs July 07, 2023 Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... Via Benzinga The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Big Pharma is facing a patent cliff that could siphon off billions in revenue. Via Investor's Business Daily BELLUS Health: Q1 Earnings Insights May 12, 2023 Via Benzinga GSK Stock: A Value Trap or a Hidden Gem? April 27, 2023 GSK, formerly known as GlaxoSmithKline, is struggling after a complicated earnings season. Here's why GSK stock is still a buy. Via InvestorPlace Where BELLUS Health Stands With Analysts April 19, 2023 Via Benzinga 3 Biotechs That Might Get Bought Out in 2023 April 26, 2023 Biotech is expected to be a hotbed of mergers and acquisitions this year. Via The Motley Fool Was This Acquisition a Savvy Play by This Big Pharma Stock? April 26, 2023 The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health. Via The Motley Fool Second Quarter Outlook For Biotech Stocks April 25, 2023 Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity. Via Talk Markets Why This Nasdaq Stock Caught Fire This Week April 20, 2023 A wave of bargain buying benefited the gene therapy company's shares this week. Via The Motley Fool Why Shares of Bellus Health Skyrocketed This Week April 20, 2023 The company has received a buyout offer from GSK. Via The Motley Fool Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings April 18, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones turning higher on Tuesday. The Dow traded up 0.04% to 34,000.96 while the NASDAQ fell 0.13% to 12,141.79. The S&P 500, also rose,... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 April 19, 2023 Via Benzinga Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates April 18, 2023 U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.42% to 33,842.93 while the NASDAQ fell 0.10% to 12,146.16. The S&P 500,... Via Benzinga Why BELLUS Health Stock Is Rocketing Higher Today April 18, 2023 A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today. Via The Motley Fool Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 18, 2023 Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... Via Benzinga US Stocks Mixed; Housing Starts Edge Lower In March April 18, 2023 U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 33,945.01 while the NASDAQ rose... Via Benzinga Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal April 18, 2023 Shares of its takeover candidate nearly doubled on the news. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 April 18, 2023 Via Benzinga Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories April 18, 2023 Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs Via Benzinga Why Is Gamida Cell (GMDA) Stock Up 48% Today? April 18, 2023 Gamida Cell (GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning cell therapy Omisirge. Via InvestorPlace Why Is ContraFect (CFRX) Stock Down 14% Today? April 18, 2023 ContraFect (CFRX) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange and undergoing a rally yesterday. Via InvestorPlace Why Is Bellus Health (BLU) Stock Up 98% Today? April 18, 2023 Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK). Via InvestorPlace Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket April 18, 2023 Gainers Super League Gaming, Inc. (NASDAQ: SLGG) jumped 119.8% to $0.9408 in pre-market trading. LandVault and Super League disclosed a strategic partnership to provide brands with scalable solutions... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 18, 2023 We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday! Via InvestorPlace BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session April 18, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition April 18, 2023 Via Benzinga Expert Ratings for BELLUS Health September 30, 2022 Over the past 3 months, 4 analysts have published their opinion on BELLUS Health (NASDAQ:BLU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Here's Why BELLUS Health Shares Are Diving Lower Today July 14, 2022 BELLUS Health Inc (NASDAQ: BLU) shares are trading lower by 10.80% to $9.00 Thursday morning after the company priced an offering of 16,540,541 shares at a price of $9.25 per share. Via Benzinga The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures July 14, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga U.S. Stock Futures Down Ahead Of Bank Earnings, Producer Price Index July 14, 2022 Pre-open movers Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
